Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues

Journal of Lipid Research

Volumn 37, Issue 9, 1996, Pages 2029-2040

  Ramharack, Randy ^a   Spahr, Mark A ^a   Kreick, Jeffrey S ^a   Sekerke, Catherine S ^a  

^a PFIZER INC   (United States)

Author keywords

glyceraldehyde 3 phosphate dehydrogenase; Lp a ; mRNA; plasminogen

Indexed keywords

APOLIPOPROTEIN A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIPOPROTEIN A; MESSENGER RNA; PLASMINOGEN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LIVER; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; APOLIPOPROTEINS; APOPROTEIN(A); GENE EXPRESSION REGULATION; LIPOPROTEIN(A); LIVER; MACACA FASCICULARIS; MALE; PLASMINOGEN; REGRESSION ANALYSIS; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0029795399     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Schaefer, E. J., S. Lamon-Fava, J. L. Jenner, J. R. McNamara, J. M. Ordovas, C. E. Davis, J. M. Abolafia, K. Lippel, and R. I. Levy. 1994. Lipoprotein[a] levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial. J. Am. Med. Assoc. 271: 999-1003.
2. Hoefler, G., F. Harnoncourt, E. Paschke, W. Mirtl, K. H. Pfeiffer, and G. M. Kostner. 1988. Lipoprotein Lp[a]. A risk factor for myocardial infarction. Arteriosclerosis. 8: 398-401.
3. Dahlen, G. H., J. R. Guyton, M. Attar, J. A. Farmer, J. A. Kautz, and A. M. Gotto. 1986. Association of levels of lipoprotein Lp[a] plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74: 758-765.
4. Kostner, G. M., P. Avogaro, G. Cazzolato, E. Marth, G. Bittolo Bon, and G. B. Qunici. 1981. Lipoprotein Lp[a] and the risk for myocardial infarction. Atherosclerosis. 38: 51-61.
5. Armstrong, V. W., P. Cremer, E. Eberle, A. Manke, F. Schulze, H. Wieland, H. Kreuzer, and D. Seidel. 1986. The association between serum Lp[a] concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis. 62: 249-257.
6. Wiklund, O., B. Angelin, S. O. Olofsson, M. Eriksson, G. Fager, L. Berglund, and G. Bondjers. 1990. Apolipoprotein[a] and ischaemic heart disease in familial hypercholesterolaemia. Lancet. 335: 1360-1363.
7. Rhoads, G. G., G. H. Dahlen, K. Berg, N. E. Morton, and A. L. Dannenberg. 1986. Lp[a] lipoprotein as a risk factor for myocardial infarction. J. Am. Med. Assoc. 256: 2540-2544.
8. Rosengren, A., L. Wilhelmsen, E. Eriksson, B. Risberg, and H. Wedel. 1990. Lipoprotein[a] and coronary heart disease: a prospective case-control study in a population sample of middle aged men. Br. Med. J. 301: 1248-1251.
9. Sandholzer, C., E. Boerwinkle, N. Saha, M. C. Tong, and G. Utermann. 1992. Apolipoprotein[a] phenotypes, Lp[a] concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo[a] gene in coronary heart disease. J. Clin. Invest. 89: 1040-1046.
10. Mölgaard, J., I. C. Klausen, C. Lassvik, O. F;aergeman, L. U. Gerdes, and A. G. Olsson. 1992. Significant association between low-molecular-weight apolipoprotein[a] isoforms and intermittent claudication. Arterioscler. Thromb. 12: 895-901.
11. Nagayama, M., Y. Shinohara, and T. Nagayama. 1994. Lipoprotein[a] and ischemic cerebrovascular disease in young adults. Stroke. 25: 74-78.
12. Jurgens, G., and P. Koltringer. 1987. Lipoprotein[a] in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. Neurology. 37: 513-515.
13. Zenker, G., P. Koltringer, G. Bone, K. Niederkorn, K. Pfeiffer, and G. Jurgens. 1986. Lipoprotein[a] as a strong indicator for cerebrovascular disease. Stroke. 17: 942-945.
14. Koltringer, P., and G. Jurgens. 1985. A dominant role of lipoprotein[a] in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis. Atherosclerosis. 58: 187-198.
15. Murai, A., T. Miyahara, N. Fujimoto, M. Matsuda, and M. Kameyama. 1986. Lp[a] lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis. 59: 199-204.
16. Shintani, S., S. Kikuchi, H. Hamaguchi, and T. Shiigai. 1993. High serum lipoprotein[a] levels are an independent risk factor for cerebral infarction. Stroke. 24: 965-969.
17. Hoff, H. F., G. J. Beck, C. I. Skibinski, G. Jurgens, J. O'Neil, J. Kramer, and B. Lytle. 1988. Serum Lp[a] level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation. 77: 1238-1244.
18. Cushing, G. L., J. W. Gaubatz, M. L. Nava, B. J. Burdick, T. M. Bocan, J. R. Guyton, D. Weilbaecher, M. E. DeBakey, G. M. Lawrie, and J. D. Morrisett. 1989. Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis. 9: 593-603.
19. Tenda, K., T. Saikawa, T. Maeda, Y. Sato, H. Niwa, T. Inoue, H. Yonemochi, T. Maruyama, N. Shimoyama, S. Aragaki, and et al. 1993. The relationship between serum lipoprotein[a] and restenosis after initial elective percutaneous transluminal coronary angioplasty. Jpn. Circ. J. 57: 789-795.
20. Hearn, J. A., B. C. Donohue, H. Ba'albaki, J. S. Douglas, S. B. King, N. J. Lembo, G. S. Roubin, and D. S. Sgoutas. 1992. Usefulness of serum lipoprotein [a] as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 69: 736-739.
21. Chiesa, G., H. H. Hobbs, M. L. Koschinsky, R. M. Lawn, S. D. Maika, and R. E. Hammer. 1992. Reconstitution of lipoprotein[a] by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein[a]. J. Biol. Chem. 267: 24369-24374.
22. Koschinsky, M. L., G. P. Côté, B. Gabel, and Y. Y. Van der Hoek. 1993. Identification of the cysteine residue in apolipoprotein[a] that mediates extracellular coupling with apolipoprotein B-100. J. Biol. Chem. 268: 19819-19825.
23. White, A. L., and R. E. Lanford. 1994. Cell surface assembly of lipoprotein[a] in primary cultures of baboon hepatocytes. J. Biol. Chem. 269: 28716-28723.
24. McLean, J. W., J. E. Tomlinson, W. J. Kuang, D. L. Eaton, E. Y. Chen, G. M. Fless, A. M. Scanu, and R. M. Lawn. 1987. cDNA sequence of human apolipoprotein[a] is homologous to plasminogen. Nature. 330: 132-137.
25. Malgaretti, N., F. Acquati, P. Magnaghi, L. Bruno, M. Pontoglio, M. Rocchi, S. Saccone, G. Della Valle, M. D'Urso, D. LePaslier, S. Ottolenghi, and R. Taramelli. 1992. Characterization by yeast artificial chromosome cloning of the linked apolipoprotein[a] and plasminogen genes and identification of the apolipoprotein[a] 5′ flanking region. Proc. Natl. Acad. Sci. USA. 89: 11584-11588.
26. Wade, D. P., J. G. Clarke, G. E. Lindahl, A. C. Liu, B. R. Zysow, K. Meer, K. Schwartz, and R. M. Lawn. 1993. 5′ Control regions of the apolipoprotein[a] gene and members of the related plasminogen gene family. Proc. Natl. Acad. Sci. USA. 90: 1369-1373.
27. Van der Hoek, Y. Y., M. E. Wittekoek, U. Beisiegel, J. J. P. Kastelein, and M. L. Koschinsky. 1993. The apolipoprotein[a] kringle IV repeats which differ from the major repeat kringle are present in variably sized isoforms. Hum. Mol. Genet. 2: 361-366.
28. Koschinsky, M. L., U. Beisiegel, D. Henne Bruns, D. L. Eaton, and R. M. Lawn. 1990. Apolipoprotein[a] size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry. 29: 640-644.
29. Geroldi, D., V. Bellotti, P. Buscaglia, G. Bonetti, C. Gazzaruso, A. Caprioli, and P. Fratino. 1993. Characterization of apo[a] polymorphism by a modified immunoblotting technique in an Italian population sample. Clin. Chim. Acta. 221: 159-169.
30. Frank, S. L., I. Klisak, R. S. Sparkes, T. Mohandas, J. E. Tomlinson, J. W. McLean, R. M. Lawn, and A. J. Lusis. 1988. The apolipoprotein[a] gene resides on human chromosome 6q26-27, in close proximity to the homologous gene for plasminogen. Hum. Genet. 79: 352-356.
31. Wade, D. P., G. E. Lindahl, and R. M. Lawn. 1994. Apolipoprotein[a] gene transcription is regulated by liver-enriched trans-acting factor hepatocyte nuclear factor 1α. J. Biol. Chem. 269: 19757-19765.
32. Tomlinson, J. E., J. W. McLean, and R. M. Lawn. 1989. Rhesus monkey apolipoprotein[a]. Sequence, evolution, and sites of synthesis. J. Biol. Chem. 264: 5957-5965.
33. Azrolan, N., D. Gavish, and J. L. Breslow. 1991. Plasma lipoprotein[a] concentration is controlled by apolipoprotein[a] (apo[a]) protein size and the abundance of hepatic apo[a] mRNA in a cynomolgus monkey model. J. Biol. Chem. 266: 13866-13872.
34. Ramharack, R., M. S. Spahr, G. W. Hicks, K. A. Kieft, D. W. Brammer, L. L. Minton, and R. S. Newton. 1995. Gemfibrozil significantly lowers cynomolgus monkey plasma lipoprotein[a]-protein and liver apolipoprotein[a] mRNA levels. J. Lipid Res. 36: 1294-1304.
35. Forsgren, M., B. Raden, M. Israelsson, K. Larsson, and L. O. Heden. 1987. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett. 213: 254-260.
36. Taddei-Peters, W. C., B. T. Butman, G. R. Jones, T. M. Venetta, P. F. Macomber, and J. H. Ransom. 1993. Quantification of lipoprotein[a] particles containing various apolipoprotein[a] isoforms by a monoclonal anti-apo[a] capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay. Clin. Chem. 39: 1382-1389.
37. Zhang, D. E., X. Ge, J. P. Rabek, and J. Papaconstantinou. 1991. Functional analysis of the trans-acting factor binding sites of the mouse alpha-fetoprotein proximal promoter by site-directed mutagenesis. J. Biol. Chem. 266: 21179-21185.
38. Feuerman, M. H., R. Godbout, R. S. Ingram, and S. M. Tilghman. 1989. Tissue-specific transcription of the mouse alpha-fetoprotein gene promoter is dependent on HNF-1. Mol. Cell Biol. 9: 4204-4212.
39. Herbst, R. S., N. Friedman, J. E. Darnell, Jr., and L. E. Babiss. 1989. Positive and negative regulatory elements in the mouse albumin enhancer. Proc. Natl. Acad. Sci. USA. 86: 1553-1557.
40. Zaret, K. S., C. M. DiPersio, D. A. Jackson, W. J. Montigny, and D. L. Weinstat. 1988. Conditional enhancement of liver-specific gene transcription. Proc. Natl. Acad. Sci. USA. 85: 9076-9080.
41. Utermann, G., H. J. Menzel, H. G. Kraft, H. C. Duba, H. G. Kemmler, and C. Seitz. 1987. Lp[a] glycoprotein phenotypes. Inheritance and relation to Lp[a]-lipoprotein concentrations in plasma. J. Clin. Invest. 80: 458-465.
42. White, A. L., D. L. Rainwater, and R. E. Lanford. 1993. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J. Lipid Res. 34: 509-517.
43. Durovic, S., W. Mrz, S. Frank, H. Scharnagl, M. W. Baumstark, R. Zechner, and G. M. Kostner. 1994. Decreased binding of apolipoprotein [a] to familial defective apolipoprotein B-100 (Arg3500 → Gln). A study of the assembly of recombinant apolipoprotein [a] with mutant low density lipoproteins. J. Biol. Chem. 269: 30320-30325.
44. Rader, D. J., W. A. Mann, W. Cain, H-G. Kraft, D. Usher, L. A. Zech, J. M. Hoeg, J. Davignon, P. Lupien, M. Grossman, J. M. Wilson, and H. B. Brewer, Jr. 1995. The low density lipoprotein receptor is not required for normal catabolism of Lp[a] in humans. J. Clin. Invest. 95: 1403-1408.
45. Elshourbagy, N. A., W. S. Laio, R. W. Mahley, and J. M. Taylor. 1985. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA. 82: 203-207.
46. Newman, T. C., P. A. Dawson, L. L. Rudel, and D. L. Williams. 1985. Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates. J. Biol. Chem. 260: 2452-2457.
47. Grainger, D. J., H. L. Kirschenlohr, J. C. Metcalfe, P. L. Weissberg, D. P. Wade, and R. M. Lawn. 1993. Proliferation of human smooth muscle cells promoted by lipoprotein[a]. Science. 260: 1655-1658.
48. Grainger, D. J., P. R. Kemp, A. C. Liu, R. M. Lawn, and J. C. Metcalfe. 1994. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein[a] mice. Nature. 370: 460-462.
49. Desmarais, R. L., I. J. Sarembock, C. R. Ayers, S. M. Vernon, E. R. Powers, and L. W. Gimple. 1995. Elevated serum lipoprotein[a] is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 91: 1403-1409.